Results from preclinical studies have indicated that VEGFR is associated with hematogenous metastasis in renal cell carcinoma [25,26], and tumor metastasis via lymphatics can be inhibited by interference with the VEGF-C VEGFR3 interaction [27]. Here, KDR is linked to neoplasm.